| Jul 9 |
Ligand Pharmaceuticals to acquire APEIRON Biologics for $100m
|
| Jul 8 |
Ligand to Acquire Apeiron for $100 Million in Cash, Plus Up to $28 Million Based on Royalties
|
| Jul 8 |
Ligand to buy Apeiron; Roche reports another TIGIT setback
|
| Jul 8 |
Ligand to buy APEIRON Biologics for $100M, ups 2024 revenue outlook
|
| Jul 8 |
Ligand to Acquire APEIRON Biologics AG for $100 Million
|
| Jul 1 |
Lifecore Biomedical Announces Cooperation Agreement with 22NW
|
| Jun 27 |
Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years
|
| Jun 24 |
Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer
|
| Jun 19 |
Roche (RHHBY), Ascidian Team Up for RNA Exon Editing Therapeutics
|
| Jun 19 |
Terns (TERN) Gains 13.6% YTD: Will the Momentum Continue?
|
